Compass Therapeutics (CMPX) Current Leases (2023 - 2025)
Historic Current Leases for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $633000.0.
- Compass Therapeutics' Current Leases rose 1364.45% to $633000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $633000.0, marking a year-over-year increase of 1364.45%. This contributed to the annual value of $338000.0 for FY2024, which is 7176.27% down from last year.
- As of Q3 2025, Compass Therapeutics' Current Leases stood at $633000.0, which was up 1364.45% from $271000.0 recorded in Q2 2025.
- Compass Therapeutics' Current Leases' 5-year high stood at $1.2 million during Q1 2024, with a 5-year trough of $109000.0 in Q1 2025.
- Its 3-year average for Current Leases is $805454.5, with a median of $1.1 million in 2024.
- Data for Compass Therapeutics' Current Leases shows a peak YoY increase of 1364.45% (in 2025) and a maximum YoY decrease of 9109.48% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Compass Therapeutics' Current Leases stood at $1.2 million in 2023, then crashed by 71.76% to $338000.0 in 2024, then skyrocketed by 87.28% to $633000.0 in 2025.
- Its Current Leases stands at $633000.0 for Q3 2025, versus $271000.0 for Q2 2025 and $109000.0 for Q1 2025.